Lung Cancer Treatment: Types, Stages, Symptoms, Diagnosis & Care Options

Lung cancer causes more deaths than any other type of cancer – around 1.8 million each year. Even so, progress in care has enhanced both survival and quality of life for many individuals. Beginning with symptoms to watch for, this guide covers key information about current approaches to managing the disease.

Overview

What is lung cancer?

Lung cancer develops when cells grow uncontrollably in one or both lungs. Tumors form as these cells multiply rapidly, interfering with how air sacs transfer oxygen into the bloodstream.

Without treatment, malignant cells may break away and spread to other organs such as the bones, brain, or liver.

How common is lung cancer?

Lung cancer remains one of the most commonly diagnosed cancers worldwide. Around 2.5 million new cases were reported globally in 2022.

Although rates among men have declined in many regions, diagnoses among women remain stable or are increasing in some areas, highlighting the need for continued awareness and screening.

Types of Lung Cancer

Understanding the specific type of lung cancer is important because treatment approaches differ between cell types.

Non-small cell lung cancer (NSCLC)

NSCLC accounts for approximately 80–85% of lung cancer cases. It typically grows and spreads more slowly than small cell lung cancer.

Major subtypes include:

• Adenocarcinoma (common among non-smokers)
• Squamous cell carcinoma
• Large cell carcinoma

Surgery is often the primary treatment when the disease is detected early, sometimes combined with targeted therapies guided by molecular testing.

Small cell lung cancer (SCLC)

Small cell lung cancer represents about 15% of lung cancer cases and is strongly associated with long-term tobacco use.

This type grows rapidly and often spreads before symptoms appear. Because of this, treatment usually involves chemotherapy, radiation therapy, or immunotherapy rather than surgery.

Rare lung tumors

Mesothelioma

Mesothelioma affects the lining of the lungs (pleura) and is primarily caused by asbestos exposure. It often develops 30–50 years after exposure.

Carcinoid tumors

Carcinoid tumors are slow-growing neuroendocrine tumors. They are often curable with surgery if detected early and rarely spread to distant organs.

Symptoms and Early Warning Signs

Common symptoms of lung cancer

Symptoms may not appear until the disease has progressed. Common signs include:

• Persistent cough that worsens over time
• Chest pain during breathing or coughing
• Hoarseness or voice changes
• Unexplained weight loss
• Loss of appetite
• Shortness of breath or wheezing

Early signs of lung cancer

Early symptoms may resemble minor respiratory illnesses. However, certain warning signs require medical evaluation:

• Coughing up blood or rust-colored mucus
• Recurrent lung infections such as bronchitis or pneumonia
• Persistent fatigue or chest discomfort

Symptoms of metastatic lung cancer

When lung cancer spreads to other organs, symptoms depend on the affected area:

• Bone metastasis: Bone pain, especially in the back or hips
• Brain metastasis: Headaches, dizziness, seizures
• Liver metastasis: Jaundice (yellowing of skin and eyes)

Causes and Risk Factors

What causes lung cancer?

Lung cancer begins when cells lining the airways sustain genetic damage. Repeated exposure to carcinogens disrupts normal cell repair processes, eventually leading to tumor formation.

Smoking and secondhand smoke

Smoking is the leading cause of lung cancer, responsible for about 80% of deaths from the disease.

Tobacco smoke contains over 7,000 chemicals, many of which are known carcinogens.

Secondhand smoke also significantly increases risk for non-smokers.

Environmental risk factors

Radon

Radon is a naturally occurring radioactive gas that can accumulate inside homes and is the second leading cause of lung cancer.

Asbestos

Exposure to asbestos fibers can cause lung cancer and is the primary cause of mesothelioma.

Air pollution

Long-term exposure to fine particulate pollution and diesel exhaust increases lung cancer risk.

Genetic factors

People with a family history of lung cancer may have increased risk due to inherited genetic mutations or shared environmental exposures.

Lung Cancer Staging

Cancer staging helps determine the severity of the disease and guides treatment decisions.

The TNM staging system

Doctors use the TNM system to describe cancer spread:

• T (Tumor): Size and location of the primary tumor
• N (Node): Whether cancer has spread to nearby lymph nodes
• M (Metastasis): Whether cancer has spread to distant organs

Stages of non-small cell lung cancer

• Stage 0: Cancer remains within the lung lining
• Stage 1: Tumor is small and confined to the lung
• Stage 2: Cancer may involve nearby lymph nodes
• Stage 3: Cancer spreads to lymph nodes in the chest
• Stage 4: Cancer spreads to distant organs

Stages of small cell lung cancer

• Limited stage: Cancer remains confined to one side of the chest
• Extensive stage: Cancer has spread throughout the lungs or to other organs

Diagnosis and Screening

How lung cancer is diagnosed

Diagnosis typically begins with a physical exam and imaging tests, followed by tissue analysis to confirm cancer.

Imaging tests

• Chest X-ray: Often the first imaging test but may miss small tumors
• CT scan: Provides detailed images of lung structures
• PET scan: Detects active cancer cells and distant metastasis

Biopsy procedures

A biopsy confirms cancer by examining tissue under a microscope.

Bronchoscopy:
A thin tube is inserted through the airways to view the lungs and collect samples.

Needle biopsy:
A needle is inserted through the chest wall to collect tissue from a lung nodule.

Molecular and genetic testing

For NSCLC, biomarker testing identifies genetic mutations such as:

• EGFR
• ALK
• KRAS

These results guide targeted treatment options.

Lung Cancer Treatment Options

Treatment depends on:

• Cancer type
• Stage of disease
• Patient health status

Treatment by stage

Early stages (I–II):

• Surgery
• Possible chemotherapy or radiation after surgery

Locally advanced (Stage III):

• Combined chemotherapy, radiation, and immunotherapy

Metastatic disease (Stage IV):

• Targeted therapy
• Immunotherapy
• Systemic treatments

Surgery

Surgical procedures remove tumors and surrounding lung tissue.

• Lobectomy: Removal of one lung lobe (most common)
• Wedge resection: Removal of a small lung section
• Pneumonectomy: Removal of an entire lung

Radiation therapy

Radiation therapy uses focused energy beams to destroy cancer cells. Advanced techniques such as stereotactic body radiation therapy (SBRT) precisely target small tumors.

Chemotherapy

Chemotherapy uses drugs that destroy rapidly dividing cancer cells.

Treatment usually occurs in 4–6 cycles over several months.

It is often the main therapy for small cell lung cancer and may be used before or after surgery in NSCLC.

Immunotherapy

Immunotherapy helps the immune system recognize and attack cancer cells.

Common drugs include:

• Pembrolizumab (Keytruda)
• Nivolumab (Opdivo)
• Atezolizumab (Tecentriq)

These medications block the PD-1/PD-L1 pathway, allowing immune cells to target tumors more effectively.

Targeted therapy

Targeted drugs attack specific genetic mutations within tumor cells.

Examples include:

• Osimertinib for EGFR mutations
• Sotorasib for KRAS G12C mutations

These treatments often have fewer side effects than traditional chemotherapy.

Palliative care

Palliative care helps manage symptoms such as:

• Pain
• Breathing difficulty
• Fatigue

It can be used alongside curative treatment to improve quality of life.

Managing treatment side effects

Common side effects may include:

• Fatigue
• Nausea
• Hair loss

The severity often depends on treatment intensity and duration.

Prevention and Outlook

Can lung cancer be prevented?

Although not all lung cancers can be prevented, risk can be reduced by:

• Avoiding tobacco use
• Testing homes for radon
• Reducing occupational exposure to harmful substances

Survival rates

Survival varies by stage.

For localized NSCLC, the 5-year survival rate exceeds 60%. Survival decreases when cancer spreads to distant organs.

However, modern treatments continue improving long-term outcomes.

Living with lung cancer

Patients often require:

• Regular follow-up scans
• Lifestyle adjustments
• Support groups or pulmonary rehabilitation

These measures help maintain physical and emotional well-being.

Frequently Asked Questions

Is lung cancer curable?

Lung cancer may be curable when detected early (Stage I or II) and treated with surgery or radiation.

Advanced stages are usually managed as chronic conditions rather than cured.

How fast does lung cancer spread?

Small cell lung cancer spreads rapidly, often within weeks or months.

Non-small cell lung cancer typically grows more slowly but can still spread if untreated.

What is the best treatment for lung cancer?

There is no single best treatment. Therapy depends on:

• Cancer stage
• Genetic biomarkers
• Patient health

Most treatment plans combine surgery, targeted therapy, or immunotherapy.

Conclusion

Lung cancer remains a serious global health challenge, but advances in diagnosis and treatment continue to improve outcomes.

Early detection plays a critical role. Screening for high-risk individuals and recognizing symptoms early can significantly increase treatment success.

References

1. JNCCN. Non–Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology.
   https://jnccn.org/view/journals/jnccn/22/4/article-p249.xml

2. HMP Global Learning Network. 2024 NCCN Clinical Practice Guidelines Update.
   https://www.hmpgloballearningnetwork.com/site/jcp/jcp-special-report/2024-nccn-clinical-practice-guidelines-oncology-nccn-guidelines-r

3. NCCN. Guidelines for Patients: Small Cell Lung Cancer.
   https://www.nccn.org/patients/guidelines/content/PDF/SCLC-patient-guideline.pdf

4. Cancer Research Institute. Lung Cancer Immunotherapy.
   https://www.cancerresearch.org/immunotherapy-by-cancer-type/lung-cancer

5. NHS. Lung cancer – Treatment.
   https://www.nhs.uk/conditions/lung-cancer/treatment/

6. World Health Organization. Global cancer burden growing.
   https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services